Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(9 sites)
China
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Zhongda Hospital, Southeast University, Nanjing, Jiangsu The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality West China Hospital of Sichuan University, Chengdu, Sichuan Tianjin Medical University General Hospital, Tianjing, Tianjing The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University (WMU), Wenzhou, Zhejiang